Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianli Sun

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
BMC Complementary and Alternative Medicine|August 3, 2012
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patientsLing Xu, HeGen Li, ZhenYe Xu, et al.
Frontiers in Pharmacology|July 24, 2019
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialLijing Jiao, Jianfang Xu, Jianli Sun, et al.
Scientific Reports|April 25, 2017
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer PatientsLijing Jiao, Changsheng Dong, Jiaxiang Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 24, 2018
Genome-Wide Association and Functional Studies Identify <i>SCML4</i> and <i>THSD7A</i> as Novel Susceptibility Genes for Coronary Artery DiseaseYang Li, Dao Wen Wang, Yundai Chen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
BMC Complementary and Alternative Medicine|August 3, 2012
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patientsLing Xu, HeGen Li, ZhenYe Xu, et al.
Frontiers in Pharmacology|July 24, 2019
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialLijing Jiao, Jianfang Xu, Jianli Sun, et al.
Scientific Reports|April 25, 2017
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer PatientsLijing Jiao, Changsheng Dong, Jiaxiang Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 24, 2018
Genome-Wide Association and Functional Studies Identify <i>SCML4</i> and <i>THSD7A</i> as Novel Susceptibility Genes for Coronary Artery DiseaseYang Li, Dao Wen Wang, Yundai Chen, et al.
Pageof 5